- Home
- ESS vs HOLX Comparison
ESS vs HOLX Comparison
Compare ESS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESS
- HOLX
- Stock Information
- Founded
- ESS 1971
- HOLX 1985
- Country
- ESS United States
- HOLX United States
- Employees
- ESS N/A
- HOLX N/A
- Industry
- ESS Real Estate Investment Trusts
- HOLX Medical Electronics
- Sector
- ESS Real Estate
- HOLX Health Care
- Exchange
- ESS Nasdaq
- HOLX Nasdaq
- Market Cap
- ESS 18.7B
- HOLX 16.3B
- IPO Year
- ESS 1994
- HOLX 1990
- Fundamental
- Price
- ESS $294.71
- HOLX $64.50
- Analyst Decision
- ESS Hold
- HOLX Buy
- Analyst Count
- ESS 22
- HOLX 14
- Target Price
- ESS $297.35
- HOLX $85.42
- AVG Volume (30 Days)
- ESS 466.1K
- HOLX 2.3M
- Earning Date
- ESS 02-04-2025
- HOLX 02-05-2025
- Dividend Yield
- ESS 3.49%
- HOLX N/A
- EPS Growth
- ESS 82.71
- HOLX 50.83
- EPS
- ESS 11.54
- HOLX 3.16
- Revenue
- ESS $1,826,249,000.00
- HOLX $4,039,000,000.00
- Revenue This Year
- ESS N/A
- HOLX $5.33
- Revenue Next Year
- ESS $3.89
- HOLX $5.72
- P/E Ratio
- ESS $25.54
- HOLX $20.44
- Revenue Growth
- ESS 8.71
- HOLX 1.76
- 52 Week Low
- ESS $225.40
- HOLX $62.70
- 52 Week High
- ESS $317.73
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- ESS 58.96
- HOLX 34.25
- Support Level
- ESS $287.37
- HOLX $62.70
- Resistance Level
- ESS $293.79
- HOLX $65.18
- Average True Range (ATR)
- ESS 6.25
- HOLX 1.55
- MACD
- ESS 0.60
- HOLX -0.18
- Stochastic Oscillator
- ESS 71.85
- HOLX 17.36
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 254 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.